John Welch
Family Medicine · Palmyra, PANPI 1588629042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,404 and has fallen 93.0% since, to $99 in 2025.
Across 240 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$462
- AbbVie$449
- Lilly USA, LLC$345
- AstraZeneca$316
- GSK$227
- Pfizer$144
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,691100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $462 |
| AbbVie(2 entities) | 28 | $449 |
| Lilly USA, LLC | 19 | $345 |
| AstraZeneca | 19 | $316 |
| GSK | 23 | $227 |
| Pfizer | 10 | $144 |
| Johnson & Johnson | 11 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $132 |
| Amarin Pharma, Inc. | 7 | $131 |
| Amgen | 8 | $110 |
| Genentech USA, Inc. | 5 | $85 |
| Novartis | 5 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Kowa Pharmaceuticals America, Inc. | 6 | $82 |
| Teva Pharmaceuticals USA, Inc. | 5 | $80 |
| Merck | 5 | $74 |
| E.r. Squibb & Sons, L.L.C. | 4 | $73 |
| Sanofi-aventis U.S. LLC | 6 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Bayer | 3 | $54 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Daiichi Sankyo Inc. | 3 | $52 |
| Boehringer Ingelheim | 4 | $51 |
| Astellas Pharma US Inc | 3 | $47 |
| Sanofi Pasteur Inc. | 3 | $45 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Dexcom, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Clarus Therapeutics Inc. | 1 | $22 |
| Mannkind Corporation | 1 | $14 |
How this compares
$3,702 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Palmyra
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.